Browse investments

Invest in Latigo Biotherapeutics, Inc. on Stash

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction.

To buy fractional shares of Latigo Biotherapeutics, Inc. stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Ticker: LTGO

Latigo Biotherapeutics, Inc.

$15.25

-4.81%

(1W)

$

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years. Historical performance data are provided “as is” and solely for information purposes, is not advice or for trading purposes, does not reflect an investment strategy, may be subject to pricing delays, should not be used for tax reporting, may not reflect actual performance, and are gross of Stash fees. Market data provided by LSEG Data & Analytics in partnership with: LSEG FX in collaboration with: LSEG Risk Intelligence. Stash cannot and does not represent or guarantee that any of the information available via LSEG Data & Analytics is accurate, reliable, current, complete or appropriate for your needs. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine performance and yield are not a reliable indicator of current and future results.

LTGO Performance Breakdown

Share Price

$15.25

Today's change

6.64%

Year to date change (YTD)

-16.44%

Dividend yield

0.0

Last dividend paid

N/A

Last dividend pay date

N/A

About LTGO

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction. Its two product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors designed to inhibit the transmission of pain. It is also advancing additional Nav1.8 candidates that can address alternative formulation and delivery approaches. The Company's lead product candidate, LTG-001, is an oral Nav1.8 inhibitor designed to provide fast-acting, opioid-sparing relief for the treatment of acute pain. LTG-321 is its next-generation candidate for the inhibition of Nav1.8, being developed for the treatment of chronic musculoskeletal pain, starting with osteoarthritis (OA). LTG-001 and LTG-321 are in clinical development, and LTG-418 and the Company's other product candidates and programs are in preclinical development or discovery stages.

Latigo Biotherapeutics, Inc. Stock Ticker

LTGO

For more information

https://latigobio.com/

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years. Historical performance data are provided “as is” and solely for information purposes, is not advice or for trading purposes, does not reflect an investment strategy, may be subject to pricing delays, should not be used for tax reporting, may not reflect actual performance, and are gross of Stash fees. Market data provided by LSEG Data & Analytics in partnership with: LSEG FX in collaboration with: LSEG Risk Intelligence. Stash cannot and does not represent or guarantee that any of the information available via LSEG Data & Analytics is accurate, reliable, current, complete or appropriate for your needs. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine performance and yield are not a reliable indicator of current and future results.

Invest in Latigo Biotherapeutics, Inc. on Stash

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction.

To buy fractional shares of Latigo Biotherapeutics, Inc. stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Certain companies are volatile

Certain companies can be volatile, meaning the stock price fluctuates significantly. Don’t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.

Latigo Biotherapeutics, Inc. stock news

CNBC

United Airlines slashes 2026 profit outlook on fuel prices, but travelers keep booking despite higher fares

United Airlines' fourth-quarter earnings outlook came in below Wall Street estimates. The outlook means United expects lower earnings overall for 2026 as fuel costs bite.

about 9 hours ago

Business Insider

Elon Musk says Tesla and SpaceX have set up committees to explore a merger

SpaceX and Tesla have each established exploratory committees to discuss a possible merger, Elon Musk said. Musk, who said he can't participate in the talks, gave the update during Tesla's Q3 earnings call.

about 8 hours ago

24/7 Wall Street

AEP's Dividend Keeps Growing. But Can the Utility Afford Bigger Payouts?

AEP just raised its dividend for the fifteenth straight year, but the cash flow math tells a different story than the press release.

about 10 hours ago

CNBC

Boeing wins FAA approval for 737 Max 10 after years of delays

The FAA certified Boeing's 737 Max 10, the largest model in the best-selling family of aircraft. The plane, which was set to start flying in 2020, is years behind schedule after safety crises and engineering changes.

about 10 hours ago

Why invest with Stash?

Fractional shares

Thousands of stocks and ETFs. No investing minimums.

Unlimited trades

Plus no add-on trading commission fees.^†

Diversification analysis

Custom investment recommendations can help you diversify.

Automatic investing

Dividend reinvestment,⁸ recurring investments, and more.

The Stock-Back® Card

We’ll give you matching stock in companies you shop at.¹

Learn how to invest

Get professional advice and education at every step.

How to buy Latigo Biotherapeutics, Inc. stock on Stash

Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

Latigo Biotherapeutics, Inc.’s share price is determined by its bid-ask spread, which is the difference between the price that buyers are willing to pay and the price that sellers are willing to accept. Latigo Biotherapeutics, Inc.’s price can fluctuate throughout the course of each trading day—when you buy Latigo Biotherapeutics, Inc. through Stash, we execute the market order during our next available trading window (we have two a day). At Stash, we don’t recommend trying to predict the market when buying investments. We believe it can be a better strategy to buy quality investments you believe in, then hang onto them.

Use our historic performance chart to see real-time Latigo Biotherapeutics, Inc. stock price and the Latigo Biotherapeutics, Inc. news feed to help further your research before investing in fractional shares with any dollar amount you choose.

Stash offers one subscription plan: The Stash Plan.

The Stash Plan can help you reach different goals and offers a unique combination of financial accounts and features. This plan includes access to a personal brokerage account—also known as your personal investment account. You can use your Stash personal portfolio to purchase any of the available investments on our platform, as well as access our suite of automatic saving and investing tools. Learn more about Stash pricing.

Once your market order of Latigo Biotherapeutics, Inc. stock is complete, you'll officially be a shareholder of Latigo Biotherapeutics, Inc.!